Insider · CIK 0001864158
David Alan Campbell
Files at JANX (Janux Therapeutics, Inc.). First filing Oct 30, 2024, latest Jan 8, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
JANX: Janux Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 27Weak | Janux Therapeutics, Inc. | $300k 5,000 shares | -2% | - | |
| 43Moderate | Janux Therapeutics, Inc. | $1.4M 25,000 shares | -10% | - | |
| 30Weak | Janux Therapeutics, Inc. | $1.0M 15,000 shares | -6% | - | |
| 30Weak | Janux Therapeutics, Inc. | $1.3M 25,000 shares | -9% | - | |
| 38Weak | Janux Therapeutics, Inc. | $1.3M 25,000 shares | -8% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 7, 2025 | JANX Janux Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -5,000 | $60.00 | $300k | 293,054 | Jan 8, 2025 |
| Jan 2, 2025 | JANX Janux Therapeutics, Inc. | AGrant or award Common Stock | +81,000 | $0.00 | $0 | 298,054 | Jan 3, 2025 |
| Jan 2, 2025 | JANX Janux Therapeutics, Inc. | AGrant or award Stock option (right to buy)derivative | +283,500 | $0.00 | $0 | 283,500 | Jan 3, 2025 |
| Dec 24, 2024 | JANX Janux Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -25,000 | $56.19 | $1.4M | 217,054 | Dec 27, 2024 |
| Dec 3, 2024 | JANX Janux Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -15,000 | $67.00 | $1.0M | 242,054 | Dec 3, 2024 |
| Nov 25, 2024 | JANX Janux Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -18,281 | $51.43 | $940k | 263,773 | Nov 27, 2024 |
| Nov 25, 2024 | JANX Janux Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -6,719 | $52.04 | $350k | 257,054 | Nov 27, 2024 |
| Oct 28, 2024 | JANX Janux Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -13,897 | $53.22 | $740k | 293,157 | Oct 30, 2024 |
| Oct 28, 2024 | JANX Janux Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -11,103 | $53.94 | $599k | 282,054 | Oct 30, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.